59.60GBp+3.83%Mkt Cap: 272.65M $P/E: 29.801d ago
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and poi…
Indicators:|
Key Statistics
Company
Market Cap272.65M $
Enterprise Value250.18M $
Revenue (TTM)52.93M $
Gross Profit36.63M $
Net Income (TTM)7.61M $
Revenue/Share0.1283 USD
Last Price59.60 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees97
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)29.80
P/E (Forward)14.93
PEG—
EV/EBITDA16.10
EV/Revenue4.73
P/S5.15
P/B3.68
EPS (TTM)0.02
EPS (Forward)0.04
52W Range
53.8424% of range77.60
52W High77.60 GBp
52W Low53.84 GBp
Profitability
Gross Margin69.20%
Oper. Margin20.85%
EBITDA Margin29.36%
Profit Margin14.37%
ROE10.36%
ROA9.19%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF16.74M $
CapEx (TTM)1.63M $
FCF Margin22.36%
FCF Yield4.34%
Net Debt-20.54M $
Net Debt/EBITDA-1.32
Balance Sheet
Debt/Equity0.01
Current Ratio3.81
Quick Ratio3.12
Book Value/Sh0.1620 GBp
Cash/Share0.0480 GBp
Dividends
Fwd Div Rate0.0200 GBp
Trail. Div Rate0.0160 GBp
Div. Yield2.79%
5Y Avg Yield—
Payout Ratio76.22%
Ex-Div DateMay 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)81.20 GBp
Upside (mean)+36.2%
Target Range77.00 GBp – 86.00 GBp
GBp77.00+36.2% to meanGBp86.00
# Analysts5
Ownership
Shares Out.420.87M
Float329.25M
Insiders20.93%
Institutions65.68%
Technical
SMA 5060.80 (-2.0%)
SMA 20065.14 (-8.5%)
Beta-0.06
S&P 52W Chg20.05%
Avg Vol (30d)941.00K
Avg Vol (10d)878.22K
Technical Indicators
RSI (14)53.1
MACD-0.7174
MACD Signal-0.9000
MACD Hist.+0.1826
BB Upper61.57 GBp
BB Middle58.32 GBp
BB Lower55.07 GBp
BB Width11.13%
ATR (14)3.287 GBp
Vol Ratio (20d)3.19x